Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Elutia Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +4 vs. Q1 2024
- Shares held
- 8.97M
- +3.28M (+57.7%) vs. Q1 2024
- Total value
- $44.5M
- +$26.6M (+148.3%) vs. Q1 2024
- New holders
- 5
- 10 more added
- Sold out
- 1
- 5 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELUT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $13.8M |
| Q1 2026 | 35 | $16.0M |
| Q4 2025 | 33 | $11.1M |
| Q3 2025 | 31 | $16.1M |
| Q2 2025 | 28 | $34.4M |
| Q1 2025 | 31 | $43.6M |
| Q4 2024 | 32 | $49.3M |
| Q3 2024 | 29 | $46.7M |
| Q2 2024 | 26 | $44.5M |
| Q1 2024 | 22 | $17.9M |
| Q4 2023 | 24 | $14.9M |
| Q3 2023 | 21 | $9.20M |
| Q2 2023 | 19 | $7.23M |
| Q1 2023 | 18 | $4.20M |
| Q4 2022 | 19 | $18.4M |
| Q3 2022 | 17 | $24.0M |
| Q2 2022 | 17 | $23.6M |
| Q1 2022 | 17 | $19.4M |
| Q4 2021 | 15 | $19.8M |
| Q3 2021 | 17 | $13.2M |
| Q2 2021 | 24 | $19.7M |
| Q1 2021 | 31 | $23.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Elutia Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 1 | $5 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 29 | $144 | 0.00% | +5+20.8% | Added |
| Royal Bank of Canada | 203 | $1.00K | 0.00% | −36−15.1% | Reduced |
| Federated Hermes, Inc. | 342 | $1.70K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 625 | $3.10K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,245 | $21.1K | 0.00% | −1,029−19.5% | Reduced |
| Arcus Capital Partners, LLC | 10,000 | $49.6K | 0.02% | +10,000 | New |
| Jane Street Group, LLC | 10,497 | $52.1K | 0.00% | +10,497 | New |
| Northern Trust Corp | 13,809 | $68.5K | 0.00% | 00.0% | Unchanged |
| Verdence Capital Advisors LLC | 14,410 | $71.5K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 17,511 | $86.9K | 0.00% | −1,947−10.0% | Reduced |
| Bank of America Corp | 23,709 | $117.6K | 0.00% | +125+0.5% | Added |
| EAM Investors, LLC | 25,260 | $125.3K | 0.02% | +25,260 | New |
| BlackRock Inc. | 27,566 | $136.7K | 0.00% | +12,328+80.9% | Added |
| UBS Group AG | 32,579 | $161.6K | 0.00% | +32,079+6,415.8% | Added |
| Renaissance Technologies LLC | 53,616 | $265.9K | 0.00% | +18,000+50.5% | Added |
| Alyeska Investment Group, L.P. | 91,977 | $456.2K | 0.00% | +91,977 | New |
| Geode Capital Management, LLC | 125,361 | $621.9K | 0.00% | +7,052+6.0% | Added |
| Kennedy Capital Management, Inc. | 200,000 | $992.0K | 0.02% | +200,000 | New |
| Knollwood Investment Advisory, LLC | 409,223 | $2.03M | 0.23% | 00.0% | Unchanged |
| Vanguard Group Inc | 485,506 | $2.41M | 0.00% | +69,796+16.8% | Added |
| Perkins Capital Management Inc | 780,102 | $3.87M | 3.65% | −17,500−2.2% | Reduced |
| Birchview Capital, LP | 1,551,655 | $7.70M | 7.11% | −103,529−6.3% | Reduced |
| Silverarc Capital Management, LLC | 1,603,580 | $7.95M | 1.96% | +1,525,000+1,940.7% | Added |
| AIGH Capital Management LLC | 1,697,316 | $8.42M | 4.11% | +1,260,750+288.8% | Added |
| Nantahala Capital Management, LLC | 1,795,697 | $8.91M | 0.89% | +145,697+8.8% | Added |
| Wells Fargo & Company | 0 | $0 | 0.00% | −112−100.0% | Sold out |